<?xml version='1.0' encoding='utf-8'?>
<document id="12170391"><sentence text="Some common issues in the use of antiepileptic drugs." /><sentence text="Since 1993, eight new antiepileptic drugs (AEDs) have become available in the United States for the treatment of epilepsy: felbamate, gabapentin, lamotrigine, topiramate, tiagabine, levetiracetam, oxcarbazepine, and zonisamide"><entity charOffset="123-132" id="DDI-PubMed.12170391.s2.e0" text="felbamate" /><entity charOffset="134-144" id="DDI-PubMed.12170391.s2.e1" text="gabapentin" /><entity charOffset="146-157" id="DDI-PubMed.12170391.s2.e2" text="lamotrigine" /><entity charOffset="159-169" id="DDI-PubMed.12170391.s2.e3" text="topiramate" /><entity charOffset="171-180" id="DDI-PubMed.12170391.s2.e4" text="tiagabine" /><entity charOffset="182-195" id="DDI-PubMed.12170391.s2.e5" text="levetiracetam" /><entity charOffset="197-210" id="DDI-PubMed.12170391.s2.e6" text="oxcarbazepine" /><entity charOffset="216-226" id="DDI-PubMed.12170391.s2.e7" text="zonisamide" /><pair ddi="false" e1="DDI-PubMed.12170391.s2.e0" e2="DDI-PubMed.12170391.s2.e0" /><pair ddi="false" e1="DDI-PubMed.12170391.s2.e0" e2="DDI-PubMed.12170391.s2.e1" /><pair ddi="false" e1="DDI-PubMed.12170391.s2.e0" e2="DDI-PubMed.12170391.s2.e2" /><pair ddi="false" e1="DDI-PubMed.12170391.s2.e0" e2="DDI-PubMed.12170391.s2.e3" /><pair ddi="false" e1="DDI-PubMed.12170391.s2.e0" e2="DDI-PubMed.12170391.s2.e4" /><pair ddi="false" e1="DDI-PubMed.12170391.s2.e0" e2="DDI-PubMed.12170391.s2.e5" /><pair ddi="false" e1="DDI-PubMed.12170391.s2.e0" e2="DDI-PubMed.12170391.s2.e6" /><pair ddi="false" e1="DDI-PubMed.12170391.s2.e0" e2="DDI-PubMed.12170391.s2.e7" /><pair ddi="false" e1="DDI-PubMed.12170391.s2.e1" e2="DDI-PubMed.12170391.s2.e1" /><pair ddi="false" e1="DDI-PubMed.12170391.s2.e1" e2="DDI-PubMed.12170391.s2.e2" /><pair ddi="false" e1="DDI-PubMed.12170391.s2.e1" e2="DDI-PubMed.12170391.s2.e3" /><pair ddi="false" e1="DDI-PubMed.12170391.s2.e1" e2="DDI-PubMed.12170391.s2.e4" /><pair ddi="false" e1="DDI-PubMed.12170391.s2.e1" e2="DDI-PubMed.12170391.s2.e5" /><pair ddi="false" e1="DDI-PubMed.12170391.s2.e1" e2="DDI-PubMed.12170391.s2.e6" /><pair ddi="false" e1="DDI-PubMed.12170391.s2.e1" e2="DDI-PubMed.12170391.s2.e7" /><pair ddi="false" e1="DDI-PubMed.12170391.s2.e2" e2="DDI-PubMed.12170391.s2.e2" /><pair ddi="false" e1="DDI-PubMed.12170391.s2.e2" e2="DDI-PubMed.12170391.s2.e3" /><pair ddi="false" e1="DDI-PubMed.12170391.s2.e2" e2="DDI-PubMed.12170391.s2.e4" /><pair ddi="false" e1="DDI-PubMed.12170391.s2.e2" e2="DDI-PubMed.12170391.s2.e5" /><pair ddi="false" e1="DDI-PubMed.12170391.s2.e2" e2="DDI-PubMed.12170391.s2.e6" /><pair ddi="false" e1="DDI-PubMed.12170391.s2.e2" e2="DDI-PubMed.12170391.s2.e7" /><pair ddi="false" e1="DDI-PubMed.12170391.s2.e3" e2="DDI-PubMed.12170391.s2.e3" /><pair ddi="false" e1="DDI-PubMed.12170391.s2.e3" e2="DDI-PubMed.12170391.s2.e4" /><pair ddi="false" e1="DDI-PubMed.12170391.s2.e3" e2="DDI-PubMed.12170391.s2.e5" /><pair ddi="false" e1="DDI-PubMed.12170391.s2.e3" e2="DDI-PubMed.12170391.s2.e6" /><pair ddi="false" e1="DDI-PubMed.12170391.s2.e3" e2="DDI-PubMed.12170391.s2.e7" /><pair ddi="false" e1="DDI-PubMed.12170391.s2.e4" e2="DDI-PubMed.12170391.s2.e4" /><pair ddi="false" e1="DDI-PubMed.12170391.s2.e4" e2="DDI-PubMed.12170391.s2.e5" /><pair ddi="false" e1="DDI-PubMed.12170391.s2.e4" e2="DDI-PubMed.12170391.s2.e6" /><pair ddi="false" e1="DDI-PubMed.12170391.s2.e4" e2="DDI-PubMed.12170391.s2.e7" /><pair ddi="false" e1="DDI-PubMed.12170391.s2.e5" e2="DDI-PubMed.12170391.s2.e5" /><pair ddi="false" e1="DDI-PubMed.12170391.s2.e5" e2="DDI-PubMed.12170391.s2.e6" /><pair ddi="false" e1="DDI-PubMed.12170391.s2.e5" e2="DDI-PubMed.12170391.s2.e7" /><pair ddi="false" e1="DDI-PubMed.12170391.s2.e6" e2="DDI-PubMed.12170391.s2.e6" /><pair ddi="false" e1="DDI-PubMed.12170391.s2.e6" e2="DDI-PubMed.12170391.s2.e7" /></sentence><sentence text=" Of the older AEDs, six continue to be widely used: phenobarbital, phenytoin, primidone, ethosuximide, carbamazepine, and valproate"><entity charOffset="52-65" id="DDI-PubMed.12170391.s3.e0" text="phenobarbital" /><entity charOffset="67-76" id="DDI-PubMed.12170391.s3.e1" text="phenytoin" /><entity charOffset="78-87" id="DDI-PubMed.12170391.s3.e2" text="primidone" /><entity charOffset="89-101" id="DDI-PubMed.12170391.s3.e3" text="ethosuximide" /><entity charOffset="103-116" id="DDI-PubMed.12170391.s3.e4" text="carbamazepine" /><entity charOffset="122-131" id="DDI-PubMed.12170391.s3.e5" text="valproate" /><pair ddi="false" e1="DDI-PubMed.12170391.s3.e0" e2="DDI-PubMed.12170391.s3.e0" /><pair ddi="false" e1="DDI-PubMed.12170391.s3.e0" e2="DDI-PubMed.12170391.s3.e1" /><pair ddi="false" e1="DDI-PubMed.12170391.s3.e0" e2="DDI-PubMed.12170391.s3.e2" /><pair ddi="false" e1="DDI-PubMed.12170391.s3.e0" e2="DDI-PubMed.12170391.s3.e3" /><pair ddi="false" e1="DDI-PubMed.12170391.s3.e0" e2="DDI-PubMed.12170391.s3.e4" /><pair ddi="false" e1="DDI-PubMed.12170391.s3.e0" e2="DDI-PubMed.12170391.s3.e5" /><pair ddi="false" e1="DDI-PubMed.12170391.s3.e1" e2="DDI-PubMed.12170391.s3.e1" /><pair ddi="false" e1="DDI-PubMed.12170391.s3.e1" e2="DDI-PubMed.12170391.s3.e2" /><pair ddi="false" e1="DDI-PubMed.12170391.s3.e1" e2="DDI-PubMed.12170391.s3.e3" /><pair ddi="false" e1="DDI-PubMed.12170391.s3.e1" e2="DDI-PubMed.12170391.s3.e4" /><pair ddi="false" e1="DDI-PubMed.12170391.s3.e1" e2="DDI-PubMed.12170391.s3.e5" /><pair ddi="false" e1="DDI-PubMed.12170391.s3.e2" e2="DDI-PubMed.12170391.s3.e2" /><pair ddi="false" e1="DDI-PubMed.12170391.s3.e2" e2="DDI-PubMed.12170391.s3.e3" /><pair ddi="false" e1="DDI-PubMed.12170391.s3.e2" e2="DDI-PubMed.12170391.s3.e4" /><pair ddi="false" e1="DDI-PubMed.12170391.s3.e2" e2="DDI-PubMed.12170391.s3.e5" /><pair ddi="false" e1="DDI-PubMed.12170391.s3.e3" e2="DDI-PubMed.12170391.s3.e3" /><pair ddi="false" e1="DDI-PubMed.12170391.s3.e3" e2="DDI-PubMed.12170391.s3.e4" /><pair ddi="false" e1="DDI-PubMed.12170391.s3.e3" e2="DDI-PubMed.12170391.s3.e5" /><pair ddi="false" e1="DDI-PubMed.12170391.s3.e4" e2="DDI-PubMed.12170391.s3.e4" /><pair ddi="false" e1="DDI-PubMed.12170391.s3.e4" e2="DDI-PubMed.12170391.s3.e5" /></sentence><sentence text=" As a result, there is a relatively large number of alternative AEDs for the treatment of any given type of epilepsy" /><sentence text=" This has been particularly beneficial for patients with generalized epilepsies, both idiopathic and symptomatic" /><sentence text=" Given the wide availability of effective agents, the toxicity and pharmacokinetic profile of an AED have become major factors in the selection process" /><sentence text=" A number of common clinical situations may benefit from the abundance of AEDs" /><sentence text=" Chronic toxicity observed with some of the older AEDs such as osteoporosis, gingival hyperplasia, or alterations in reproductive endocrine function may be avoided with the use of the newer agents" /><sentence text=" The obese patient with epilepsy may benefit from the use of AEDs such as topiramate or zonisamide, which have a tendency to produce weight loss"><entity charOffset="74-84" id="DDI-PubMed.12170391.s9.e0" text="topiramate" /><entity charOffset="88-98" id="DDI-PubMed.12170391.s9.e1" text="zonisamide" /><pair ddi="false" e1="DDI-PubMed.12170391.s9.e0" e2="DDI-PubMed.12170391.s9.e0" /><pair ddi="false" e1="DDI-PubMed.12170391.s9.e0" e2="DDI-PubMed.12170391.s9.e1" /></sentence><sentence text=" In patients with a history of drug-induced skin rash, AEDs such as valproate, gabapentin, topiramate, tiagabine, and levetiracetam carry a lower risk of cross-reactivity"><entity charOffset="68-77" id="DDI-PubMed.12170391.s10.e0" text="valproate" /><entity charOffset="79-89" id="DDI-PubMed.12170391.s10.e1" text="gabapentin" /><entity charOffset="91-101" id="DDI-PubMed.12170391.s10.e2" text="topiramate" /><entity charOffset="103-112" id="DDI-PubMed.12170391.s10.e3" text="tiagabine" /><entity charOffset="118-131" id="DDI-PubMed.12170391.s10.e4" text="levetiracetam" /><pair ddi="false" e1="DDI-PubMed.12170391.s10.e0" e2="DDI-PubMed.12170391.s10.e0" /><pair ddi="false" e1="DDI-PubMed.12170391.s10.e0" e2="DDI-PubMed.12170391.s10.e1" /><pair ddi="false" e1="DDI-PubMed.12170391.s10.e0" e2="DDI-PubMed.12170391.s10.e2" /><pair ddi="false" e1="DDI-PubMed.12170391.s10.e0" e2="DDI-PubMed.12170391.s10.e3" /><pair ddi="false" e1="DDI-PubMed.12170391.s10.e0" e2="DDI-PubMed.12170391.s10.e4" /><pair ddi="false" e1="DDI-PubMed.12170391.s10.e1" e2="DDI-PubMed.12170391.s10.e1" /><pair ddi="false" e1="DDI-PubMed.12170391.s10.e1" e2="DDI-PubMed.12170391.s10.e2" /><pair ddi="false" e1="DDI-PubMed.12170391.s10.e1" e2="DDI-PubMed.12170391.s10.e3" /><pair ddi="false" e1="DDI-PubMed.12170391.s10.e1" e2="DDI-PubMed.12170391.s10.e4" /><pair ddi="false" e1="DDI-PubMed.12170391.s10.e2" e2="DDI-PubMed.12170391.s10.e2" /><pair ddi="false" e1="DDI-PubMed.12170391.s10.e2" e2="DDI-PubMed.12170391.s10.e3" /><pair ddi="false" e1="DDI-PubMed.12170391.s10.e2" e2="DDI-PubMed.12170391.s10.e4" /><pair ddi="false" e1="DDI-PubMed.12170391.s10.e3" e2="DDI-PubMed.12170391.s10.e3" /><pair ddi="false" e1="DDI-PubMed.12170391.s10.e3" e2="DDI-PubMed.12170391.s10.e4" /></sentence><sentence text=" In patients sensitive to cognitive dysfunction, drugs with a favorable profile include gabapentin, tiagabine, lamotrigine, oxcarbazepine, and levetiracetam"><entity charOffset="88-98" id="DDI-PubMed.12170391.s11.e0" text="gabapentin" /><entity charOffset="100-109" id="DDI-PubMed.12170391.s11.e1" text="tiagabine" /><entity charOffset="111-122" id="DDI-PubMed.12170391.s11.e2" text="lamotrigine" /><entity charOffset="124-137" id="DDI-PubMed.12170391.s11.e3" text="oxcarbazepine" /><entity charOffset="143-156" id="DDI-PubMed.12170391.s11.e4" text="levetiracetam" /><pair ddi="false" e1="DDI-PubMed.12170391.s11.e0" e2="DDI-PubMed.12170391.s11.e0" /><pair ddi="false" e1="DDI-PubMed.12170391.s11.e0" e2="DDI-PubMed.12170391.s11.e1" /><pair ddi="false" e1="DDI-PubMed.12170391.s11.e0" e2="DDI-PubMed.12170391.s11.e2" /><pair ddi="false" e1="DDI-PubMed.12170391.s11.e0" e2="DDI-PubMed.12170391.s11.e3" /><pair ddi="false" e1="DDI-PubMed.12170391.s11.e0" e2="DDI-PubMed.12170391.s11.e4" /><pair ddi="false" e1="DDI-PubMed.12170391.s11.e1" e2="DDI-PubMed.12170391.s11.e1" /><pair ddi="false" e1="DDI-PubMed.12170391.s11.e1" e2="DDI-PubMed.12170391.s11.e2" /><pair ddi="false" e1="DDI-PubMed.12170391.s11.e1" e2="DDI-PubMed.12170391.s11.e3" /><pair ddi="false" e1="DDI-PubMed.12170391.s11.e1" e2="DDI-PubMed.12170391.s11.e4" /><pair ddi="false" e1="DDI-PubMed.12170391.s11.e2" e2="DDI-PubMed.12170391.s11.e2" /><pair ddi="false" e1="DDI-PubMed.12170391.s11.e2" e2="DDI-PubMed.12170391.s11.e3" /><pair ddi="false" e1="DDI-PubMed.12170391.s11.e2" e2="DDI-PubMed.12170391.s11.e4" /><pair ddi="false" e1="DDI-PubMed.12170391.s11.e3" e2="DDI-PubMed.12170391.s11.e3" /><pair ddi="false" e1="DDI-PubMed.12170391.s11.e3" e2="DDI-PubMed.12170391.s11.e4" /></sentence><sentence text=" A more favorable pharmacokinetic profile is observed in the majority of the newer AEDs in contraposition to the classic agents" /><sentence text=" Good absorption, linear kinetics, and low drug-drug interaction potential make these drugs easier to use" /><sentence text=" The newer AEDs are eliminated through different combinations of liver metabolism and direct renal excretion, thus providing a wider variety of choices in patients with failure of one of these organs" /><sentence text=" Some specific problems have been found with some of the newer AEDs" /><sentence text=" Hyponatremia, known to occur rarely with carbamazepine use, appears to be more common with oxcarbazepine"><entity charOffset="42-55" id="DDI-PubMed.12170391.s16.e0" text="carbamazepine" /><entity charOffset="92-105" id="DDI-PubMed.12170391.s16.e1" text="oxcarbazepine" /><pair ddi="false" e1="DDI-PubMed.12170391.s16.e0" e2="DDI-PubMed.12170391.s16.e0" /><pair ddi="false" e1="DDI-PubMed.12170391.s16.e0" e2="DDI-PubMed.12170391.s16.e1" /></sentence><sentence text=" Felbamate has been associated with a high incidence of aplastic anemia and liver failure and should be used exceptionally"><entity charOffset="1-10" id="DDI-PubMed.12170391.s17.e0" text="Felbamate" /></sentence><sentence text=" Acute angle closure glaucoma has been observed with the use of topiramate"><entity charOffset="64-74" id="DDI-PubMed.12170391.s18.e0" text="topiramate" /></sentence><sentence text=" This complication occurs early in the course of therapy and reverses rapidly with discontinuation of the drug, so physician and patient awareness of this problem is very important" /><sentence text=" In this article several common clinical situations in the management of patients with epilepsy are presented in the form of case studies" /><sentence text=" These cases illustrate some current aspects of the use of the AEDs and will give some guidelines to help the treating physician in the increasingly complex process of AED selection" /><sentence text="" /></document>